~lj SUBCLINICAL HYPOT1:0IDISM AND POTENTIAL CONSEQUENCES SOHEESUTTON,RN,BSN
|
|
- Lynn Parsons
- 6 years ago
- Views:
Transcription
1 SUBCLINICAL HYPOTHYROIDISM I ~lj SUBCLINICAL HYPOT1:0IDISM AND POTENTIAL CONSEQUENCES By SOHEESUTTON,RN,BSN A clinical project paper submitted in partial fulfillment of the requirements for the degree: MASTER OF NURSING Washington State University Vancouver December 2010 Washington State Unlv Spokane Riverpoint Campus Library Academic Center, Suite 211 PO Box 1495 Spokane, WA (509)
2 SH and its managements II To the Faculty of Washington State University: The members of the Committee appointed to examine the clinical project by SOHEE Y. SUTTON find it satisfactory and recommend that it be accepted. Dawn Rondeau, DNP, ACNP, FNP /Jr~~~ '- ~yrasmor, MSN, FNP
3 SH and its managements III Subclinical Hypothyroidism and its Potential Consequences Abstract By Sohee Sutton, RN BSN Washington State University December 20 lo Chair: Dawn Rondeau Co-chair: Ginny Guido Subclinical hypothyroidism (SH) is a mild form of hypothyroid disorder that does not present with specific clinical signs or symptoms. At diagnosis, the level of serum thyroid stimulation (TSH) is elevated while the free thyroxin (FT4) and triiodothyronine (T3) concentrations remain normal. Thyroid hormone is an essential element in cell growth during the development of the fetus and in the metabolic activity in adults. Overt hypothyroidism and its associated adverse consequences are well studied and documented. However, the long-term effect of SH and the resultant effects on structure and functional proteins prior to overt signs and symptoms remain to be answered. The potential consequences of untreated SH and management are presented in this article.
4 SH and its managements IV TABLE of CONTENTS Table Abstract iv of Contents v Introduction Literature Ftevievv Epidemi0 logy Pathophysiology of thyroid hormone synthesis Etiology of SH Differential diagnosis Potential clinical outcomes form untreated SH Progression of Overt Hypothyroidism Cardiovascular Disorder and its Ftelated Morbidity & Mortality Diastolic heart failure Neuropsychiatric Symptoms Potential Effects in Pregnancy Case Study Screening and Diagnosis Treatment Guidelines for nurse practitioner Conclusion Fteferences Table 1 Differential Diagnosis of Subclinical Hypothyroidism Flovv Chart 1 Ftecommendations for Treatment of SH
5 SH and its managements V List of Tables 1. Table 1 Differential Diagnosis of Subclinical Hypothyroidism ~
6 SH and its managements VI List of Charts I. Flow Chart 1 Recommendations for Treatment ofsh
7 SUBCLINICAL HYPOTHYROIDISM Introduction Sub-clinical hypothyroidism (SH) is defined as an elevation in serum thyroid stimulating hormone (TSH) above 4.5 miu IL (normal range mIU/L) with normal serum free thyroxin (FT4) and triiodothyronine (T3) concentrations. The diagnosis is based on laboratory evaluation with few if any clinical signs or symptoms (Biondi & Cooper, 2008). Thyroid hormone in the form oft3 has multiple effects in the function of virtually every organ by modifying gene transcription in all tissues and alteration of the rate of protein synthesis and substrate turnover (Brent, 1994). Due to vague signs and symptoms, SH is not likely to be detected unless thyroid function screening is completed particularly for populations who have risk factors to develop SH. However, undetected and untreated SH can develop to overt hypothyroidism, cardiovascular disorders, heart failure, neuro-psychiatric symptoms and adverse impacts in pregnancy. Although a wide spectrum of abnormalities has long been recognized in patients with overt hypothyroidism, in sub-clinical hypothyroidism the diagnosis is not determined and treatment for SH is not current practice due to the controversy in benefits of the treatment (Biondi & Cooper, 2008). Literature Search Strategies A literature search was conducted using the key words, subclinical thyroid disorder, subclinical hypothyroidism, mild thyroid disorder andlwith cardiovascular disease, heart failure, and thyroid dysfunction in pregnancy and neuro-psychiatric disorder in CINAHL, MEDLINE and a textbook. The search was limited to adult subjects, journal articles and a textbook in English. A search was conducted using the date range from 1990 to Articles identified (N=396) were screened by title, then by abstract to extract irrelevant articles. Thirty-two articles meeting the inclusion criteria were identified, and were grouped
8 in three sections, instrument development to measure subclinical hypothyroidism and adverse. f ~ clinical outcomes, descriptions of the attributes, and theory development. Epidemiology of Subclinical Hypothyroidism SH and its managements In The National Health and Examination Survey (NHANES III), the prevalence of SH was 4.3% in the general population. This study also found a higher prevalence in older, European and Mexican descendants, and also in women who were also positive for the., presence of anti-thyroid antibodies. (Hollowell et ai., 2002). Research from 2008 describes the.,., prevalence of subclinical hypothyroidism ranging from 4 to 10 % of the adult population and is., increased markedly in females after the age of 45 years (Biondi & Cooper, 2008). In a.,.,.. longitudinal 20-year study in which women with both high serum TSH and high thyroid antibody concentrations were followed, overt hypothyroidism developed at a rate of 4.3 percent per year (Vanderpump et ai., 1995). Screening for early detection is recommended., ~..... given that a large proportion of the U.S. population unknowingly has laboratory evidence of., thyroid disease (Hollowell et al., 2002)... Pathophysiology of Thyroid Hormone Synthesis The thyroid hormones are essential in cell growth and development. These hormones affect the body's metabolism, growth of nails and hair, weight, temperature and energy level... To maintain cell growth, development and function, thyroid hormones availability is present constantly in the circulation and in the thyroid gland. Iodine is essential for thyroid hormone.., production. The two biologically active thyroid hormones: thyroxine (T4) and triiodothyronine.,.. (T3) are synthesized with iodine and thyroglobuline; T4 is solely a product of the thyroid.", gland, whereas T3 is a product of the thyroid and of other tissues. T4 and T3 are incorporated with thyroglobuline in the blood and in the thyroid gland. In response to low concentrations of -.." 2..
9 SH and its managements 3 thyroid hormones, Thyroid-releasing hormone (TRH) is metabolized in the hypothalamus, which stimulates the pituitary gland to secrete TSH. With a stimulation of TSH, the thyroid gland synthesizes and secretes triiodothyronine (T3) and thyroxine (T4). The hypothalamicpituitary -thyroid axis has a set point in regulating TSH and T4, T3, which are maintained within narrow margins by a regulatory feedback system (Copstead & Banasik, 2005). Etiology of Subclinical Hypothyroidism The causes of SH are the same as those of overt hypothyroidism. The potential triggers of SH include thyroid autoinunune (Hashimoto's) thyroiditis with high serum concentrations of antithyroid peroxidase (AntiTPO antibodies), persistent elevation oftsh in subacute thyroiditis, postpartum thyroiditis, and painless thyroiditis. Thyroid injury due to radiation and surgery can cause SH. Medications such as amiodarone, lithium and iodine- contrast agents may also contribute to SH. Brain tumors, inadequate T4 replacement therapy for overt hypothyroidism, toxic substances and TSH receptor gene mutation can be the culprits of SH (Bioni & Cooper, 2008). Differential Diagnosis Since SH is diagnosed with elevated serum TSH alone, other causes of an elevated TSH should be considered before diagnosing of SH. Only persistent or progressive SH should be considered as an early stage of thyroid disease. It may be difficult to distinguish symptoms between thyroid gland transient dysfunction and SH (Biondi & Cooper, 2008). Diagnosis requires frequent follow-up to distinguish between transient dysfunction or permanent and progressive disease in the thyroid gland. Possible causes of transient dysfunction include recovery from non- thyroidal illness, subacute phase of hyperthyroidism, central c,
10 SH and its managements 4 hypothyroidism with biologically inactive TSH and thyroid hormone resistance with the presence of heterophile antibodies interfering with the TSH assay. Additionally, clinicians should be aware that any previous radioiodine therapy, thyroid surgery or radiation therapy could cause a mild thyroid failure (Fatourechi, 2009). Table 1 presents the differential diagnoses of SH. Potential Clinical Outcomes from Untreated SH Progression to Overt Hypothyroidism Studies indicate that SH tends to progress to overt hypothyroidism, at a rate of 2.6% each year if thyroid peroxidase (TPO) antibodies are absent and at a rate of 4.3 % if they are present. However, in some subjects TSH levels become normalized over time. Further studies are required to determine why elevated TSH in some individuals becomes normalized. The risk -., TSH level. Those individuals with higher levels oftsh (higher risk >6.0 miu/l) and., factors for developing overt thyroid failure appear to depend on the initial measurement of the.,.. presence of thyroid peroxidase (TPO) antibodies (Bioni & Cooper, 2008) are at higher risk for developing overt hypothyroidism. During the 20-year follow -up of the Whickham cohort... - development ofsh, such as family history of thyroid dysfunction, presence oftpo antibodies and the population of women older than 60..-w...., , - study, an increased serum TSH level was predictive of the progression to overt hypothyroidism (Vanderpump, 1995). It is important to identify and screen populations with risk factors for
11 SH and its managements 5 Cardiovascular Disease (CVD) and its Related Morbidity and Mortality.. regulators Thyroid hormones cross the cell membrane, bind with intracellular receptors and act as transcription factors to modulate DNA transcription. These hormones are also important of cardiac function and cardiovascular hemodynamics. Danzi and Klein (2004) summarized the effect of thyroid hormone on the cardiovascular system. The physiologically active form of thyroid hormone, triiodothyronine (T3) binds to nuclear receptor proteins and mediates the expression of several important cardiac genes in the heart and vascular system. In the vascular system, T3 mediates the relaxation of vascular smooth muscle resulting in decreased arterial resistance and diastolic blood pressure (Danzi & Klein, 2004). The effects of T3 deficiency are increased systemic vascular resistance (SVR), diastolic dysfunction, reduced systolic function and decreased cardiac preload. These abnormalities regress with thyroid hormone replacement therapy (Biondi & Klein, 2004). In addition, SH has been associated with an increase in a number of other cardiovascular risk factors that include markers of inflammation, vascular reactivity, endothelial function, and carotid media thickness (Kvetny, Heldgaard, Bladbjerg, & Gram, 2004). Patients with sub-clinical hypothyroidism manifest many of the same changes in the cardiovascular system (CVS), but to a lesser degree than that which occurs in overt hypothyroidism (Danzi & Klein, 2004). Thyroid dysfunction, however mild, can significantly affect the CVS (Cini et a\., 2009). Subclinical hypothyroidism is a strong indicator of risk for atherosclerosis and myocardial infarction in elderly women (Hak, Pols, Visser, Drexhage, Hofman & Witteman, 2000). Diastolic Heart Failure It appears that thyroid hormone affects cardiac function not only by modulating DNA,
12 SH and its managements 6 protein but also in changing cellular function. Many cardiac genes are transcriptionally regulated by T3 and impairment oft3 signaling will not only reduce energy (ATP) turnover, - failure but also lead to changes in gene expression that contribute to pathologic remodeling and heart (Galli, Pingitore, & Iervasi, 2010). The positively regulated genes of transcription are alpha-myosin heavy chain (MHC) and the sarcoplasmic reticulum calcium ATPase that are involved with contractility. Negatively regulated genes include beta-mhc and phospholamban, which are down regulated in the presence of normal serum levels of thyroid hormone and relax the cardiac muscle (Danzi & Klein, 2004). The presence of diastolic dysfunction in the presence of a normal ejection fraction (EF) but with exercise intolerance is a predictor for the development of heart failure (HF) and leads to a higher risk of mortality in the elderly (Deswal, 2005) Research to evaluate left ventricular (LV) diastolic function with Doppler echocardiography and radionuclide ventriculography in young and middle-aged patients with Hashimoto thyroiditis and mild but persistent TSH increases were compared with euthyroid controls. This study demonstrated that subclinical hypothyroid patients had a more prolonged isovolumetric relaxation time and an impaired time -to-peak filling rate which are markers of altered LV diastolic function (Biondi, Palmieri, Lombardi & Fazio, 2002). Moreover, an increase in LV diastolic pressure will increase pulmonary capillary pressure, which can cause dyspnea, exercise limitation, and pulmonary congestion (Biondi et al., 2002). An MRI research study evaluating the cardiac function in a SH group was completed with matching of euthyroid controls. This study demonstrated in SH, there was significantly decreased cardiac preload and increased afterload that resulted in reduced stroke volume and cardiac output (Ripoli et al., 2005), which is an important negative predictor in cardiac morbidity and mortality.
13 SH and its managements 7 Neuropsychiatric Syndrome Some studies support that SH is associated with neuropsychiatric diseases including neurotic depression, anxiety, or cognitive dysfunction. A cognitive function study was reported comparing SH patients treated with Levothyroxine (LT4) treatment and a control group without treatment. The treatment group showed a significant improvement in memory performance but no improvement in affective functions (Baldini et al., 1997). However, another study suggested the lifetime frequency of depression was significantly higher in the subjects who met the criteria for SH (56%) than in those who did not (20%) suggesting that SH might lower the threshold for the occurrence of depression (Haggerty, Stern, Mason, Beckwith, Morey, &Prange, 1993). Potential Impact in Pregnancy Physiologic changes associated with pregnancy require an increased availability of thyroid hormones by 40% to 100% in order to meet the needs of mother and fetus during pregnancy. For the maternal thyroid gland to meet the demands of pregnancy it must be present, disease-free and capable ofresponding with adequate stores of iodine (Smallridge et al., 2005). Therefore, it is essential to have adequate stores of iodine for thyroid hormone production when pregnancy demands a higher output. The prevalence of SH during pregnancy is 2.3% in those with TSH levels above 6.0 mlu/liter and 0.3 % in those with TSH levels above 12 mlu/liter. Seventy percent of women with abnormal TSH values had TPO antibodies (Klein et. ai., 1991). It is well documented that clinical thyroid dysfunction has been associated with pregnancy complications such as hypertension, preterm birth, low birth weight, placental abruption, and fetal death. However,
14 SH and its managements 8 the relationship between sub-clinical hypothyroidism and pregnancy outcomes has not been well studied. Casey and colleagues (2005) reported that women with sub-clinical hypothyroidism were 3 times more likely to have a pregnancy complicated by placental abruption and preterm birth (Casey, Dashe, Wells, McIntire, Byre, Leveno & Cunningham, 2005). One report linking IQ scores and high levels of serum TSH during the second trimester demonstrated, 62 out of 186, age seven to nine year olds, had a lower lq score correlating with mother's higher than normal TSH during pregnancy (Haddow & Group, 2005). Case Study Kathy is a very pleasant 62 year-year-old woman with a history of sub-clinical hypothyroidism who presented to the emergency room with progressive shortness of breath. She complained of fatigue and intermittent dyspnea with exertion over a couple of months. She was hospitalized for several days for an evaluation to evaluate the etiology of her symptoms inclusive of a coronary angiogram that showed normal coronary arteries. She was diagnosed with idiopathic diastolic heart failure with an ejection fraction of 65 %, etiology unknown. She had no medical history other than mild hypertension that has been controlled with low dose of hydrochlorothiazide and otherwise was active and healthy. Two years prior to this event, her serum thyroid panel revealed sub-clinical hypothyroidism with an elevated TSH level of 7.7mlU/L with normal T4, T3. At this time, no further evaluation or treatment was initiated. At this hospitalization, her serum thyroid panel showed an elevated TSH level of 16m1U/L with low FT4 and T3, indicating her sub-clinical hypothyroidism had progressed to overt hypothyroidism. In this patient cardiomyocyte and resultant cardiac dysfunction was a plausible explanation for the cause of her diastolic heart failure. After a week, her condition was sufficiently stabilized to return home with a long journey of heart failure management
15 SH and its managements 9., treatment for hypothyroidism. Screening and Diagnosis Routine screening for thyroid function is controversial, not currently practiced and is not recommended by the United States Preventive Services Task Force (Helfand, 2004). However, universal screening compares favorably with other preventive medical practices in cost-effective studies especially in pregnant and elderly woman. Populations older than 45 years of age especially women show a prevalence of SH that can progress to overt disease (Hollowell et ai., 2002). In a cost effective comparison study, the cost of treatment for potential complications from untreated SH such as overt hypothyroidism, CVD, HF and neuropsychiatric syndrome is far greater than the cost of routine screening for thyroid function in the elderly (Danese, Powe, Sawin & Ladenson, 1996). Moreover, studies indicate that placental abruption and preterm birth can be the source of neurodevelopment impairment in infants that can result in lower lq scores (Casey et ai., 2005). The population of pregnant women in general has a 2.5 percent risk of adverse clinical outcomes due to SH (Haddow & Group, 2005). The American College of Obstetricians and Gynecologists and the National Guideline Clearinghouse (NCH, 2007) recommend testing only in symptomatic pregnant women or those with a family history of thyroid disease (Improvement, 2007). However, a study demonstrated that targeted thyroid function testing of only the high-risk group would miss about one third of the women that are pregnant with overt/subclinical hypothyroidism (Vaidya et ai.,2007). Given the potential complications from untreated SH, an acceptable approach to prevent adverse clinical symptoms and outcomes is routine screening oftsh serum level
16 SH and its managements 10 in those patients that are symptomatic, have a family history of thyroid dysfunction, patients who are pregnant or considering pregnancy, women older than 60 and for those with cardiovascular risk factors such as hypertension, hyperlipidemia, diabetes mellitus, and smokers. Treatment There are no guidelines for the treatment of patients with elevated serum TSH and nonnal FT4 and T3. Currently experts recommend treatment of patients with serum TSH concentration> I0 mull. Treatment for those with TSH serum level between 5 to 10 remains controversial. Data pertaining to the prevention or progression to hypothyroidism with treatment at these levels has not proven to be a treatment benefit. Arguments for not treating SH are the potential risks from thyroid replacement including cardiac arrhythmia and exacerbation of angina pectoris particularly in patients over age 65. In elderly patients, a higher TSH threshold is recommended for treatment since the upper limit of nonnal for serum TSH may be higher in this age group (Somwaru, Arnold, Joshi, Fried & Cappola, 2009). Untreated SH is associated with progression to overt hypothyroidism and adverse clinical outcomes particularly with TSH levels greater than 10m1UIL. Research supports aggressive case finding with routine screening and treatment in pregnant women, individuals older than 60 years, and those at high risk for thyroid dysfunction and cardiovascular dysfunction (Surks et ai., 2004). Development of SH tends to increases with age as does potential adverse effects on the cardiovascular system risks for cardiovascular disease, quality of life and mortality. Identification of those to screen and when to initiate treatment should be considered (Burgio, Gruttadauria, Fulco, Lunetta & Vancheri, 2005). The influencing factors
17 SH and its managements II that determine which patients to treat with TSH levels between 5-10 miu/l are those that a positive TPO lab result, women who are pregnant or considering pregnancy, and those with cardiovascular risk factors (Biondi & Cooper, 2008). The goal of treatment is the reduction of serum TSH concentration into the normal reference range. Initiation of treatment should begin with the lowest dose necessary to normalize the serum concentration starting with levothyroxine 25 to 50 mcg daily to avoid overtreatment.. After the optimal thyroxine dose has been defined, long-term monitoring of patients with an annual clinical evaluation and serum TSH measurement is appropriate (Ayala, Danese, & Landson, 2000). Recommendations for Nurse Practitioners The role of nurse practitioners is of great importance with regard to subclinical hypothyroidism. SH does not present with signs or symptoms. Yet, there is great potential for organ damage without early detection and prompt treatment particularly in pregnancy, those with a family history of SH, women 60 and over and for those who have cardiovascular risk factors. Nurse practitioners need to be aware of subclinical hypothyroidism and potential adverse clinical consequences from untreated SH. Recommendations for routine annual TSH level screening are for pregnant women, those with a family with a history of thyroid dysfunction, women 60 and older and for those who have cardiovascular risk factors. Management of SH differs depending on TSH serum concentration and demographic group. Recommendations from American Association of Clinical Endocrinologists (AACE) for treatment include patients with a TSH that is greater than 10 miu/liter or in patients with TSH levels between 5 and 10 rniu/l in pregnant women and those who show a presence of
18 SH and its managements 12 TPO antibodies (Baskin et a1., 2002). The Endocrine Society recommends thyroxine replacement in pregnant women with subclinical hypothyroidism given that the potential benefits outweigh the potential risks (Endocrine Society, 2007). Current practices are individualized with no consensus recommendations and guidelines to treat SH except in those individuals with a TSH level greater than 10 mlu/1 starting with a low dose of levothyroxine (Fatourechi, 2009). Table 2 outlines the recommendations for treatment of SH. Conclusion Subclinical hypothyroidism is a mild form of hypothyroidism disorder with vague or non -specific clinical symptoms. Diagnosis relies on an elevated serum TSH and a normal serum free thyroxine (T4). Standard recommended screenings for this disorder are not currently recommended although a substantial proportion of patients with SH eventually develop overt hypothyroidism and secondary clinical symptoms and outcomes.. Screening and treatment of the population of pregnant women, family history of thyroid dysfunction, women age over 60 and those with cardiovascular risk factors are recommended to prevent potential adverse progressive effects. Untreated SH can lead to cardiovascular disease, heart failure, neuropsychiatric symptoms, and complicated pregnancy due to untreated subclinical hypothyroidism. Further large scale randomized research is needed in the population of patients with SH evaluating the relationship of elevated TSH and normal T3, and T4 serum levels. Guideline development is needed for screening and treatment in this patient population. It is important for nurse practitioners to be aware of SH and the related potential serious clinical outcomes for untreated subclinical hypothyroidism.
19 SH and its managements 13 References Ayala, A., Danese, M., & Ladenson, P. (2000). When to treat mild hypothyroidism. Endocrino! Metab Clin North Am, 29(2), Baldini, I., Vita, A., Mauri, M., Amodei, V., Carrisi, M., Bravin, S., et al. (1997). Psychopathological and cognitive features in subclinical hypothyroidism. Prog Neuropsychopharmaco! Bio! Psychiatry, 21(6), Baskin, H., Cobin, R., Duick, D., Gharib, H., GuttIer, R., Kaplan, M., et al. (2002). American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract, 8(6), Biondi, B., & Cooper, D. (2008). The clinical significance of subclinical thyroid dysfunction. Endocr Rev, 29(1), Biondi, B., & Klein, I. (2004). Hypothyroidism as a risk factor for cardiovascular disease. Endocrine, 24(1), Biondi, B., Palmieri, E., Lombardi, G., & Fazio, S. (2002). Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med, 137( 11), Brent, G. (1994). The molecular basis of thyroid hormone action. N Eng! J Med, 331(13),
20 SH and its managements 14 Burgio, A, Gruttadauria, G., Fulco, G., Lunetta, M., & Vancheri, F. (2005). Subclinical thyroid diseases. Recenti Prog Med, 96(7-8), Casey, B., Dashe, 1., Wells, C., McIntire, D., Byrd, W., Leveno, K., et al. (2005). Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol, 105(2), Cini, G., Carpi, A, Mechanick, J., Cini, L., Camici, M., Galetta, F., et al. (2009). Thyroid hormones and the cardiovascular system: pathophysiology and interventions. Biomed Pharmacother, 63(10), Copstead, L. E., & Banasik, 1. L. (2005). Pathophysiology. ( 4 th ed., rev. )St. Louis, Mo: Elsevier Saunders. Danese, M., Powe, N., Sawin, c., & Ladenson, P. (1996). Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. lama, 276(4), Danzi, S., & Klein, I. (2004). Thyroid hormone and the cardiovascular system. Minerva Endocrinol, 29(3), Deswal, A (2005). Diastolic dysfunction and diastolic heart failure: mechanisms and epidemiology. Curr Cardiol Rep, 7(3), Endocrine Society (2007). Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. Chevy Chase (MD):
21 SH and its managements 15 Fatourechi, V. (2009). Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin Proc, 84(1), Galli, E., Pingitore, A., & Iervasi, G. (2010). The role of thyroid hormone in the pathophysiology of heart failure: Clinical evidence. Heart Fail Rev, 15(2), Haddow, 1., & Group, T. S. (2005). Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol, 106( 1), 198; author reply Haggerty, 1. 1., Stem, R., Mason, G., Beckwith, 1., Morey, c., & Prange, A. 1. (1993). Subclinical hypothyroidism: a modifiable risk factor for depression? Am J Psychiatry, 150(3), Hak, A., Pols, H., Visser, T., Drexhage, H., Hofman, A., & Witteman, 1. (2000). Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med, 132(4), Helfand, M.,. (2004). Screening for subclinical thyroid dysfunction in nonpregnant adults: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med, 140(2), Hollowell, 1., Staehling, N., Flanders, W., Hannon, W., Gunter, E., Spencer, C., et al. (2002). Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab, 87(2),
22 SH and its managements 16 Improvement, C. o. P. S. a. Q., & Liability, C. o. P. (2007). ACOG Committee Opinion No. 381: Subclinical hypothyroidism in pregnancy. Obstet Gynecol, 110(4), Klein, R., Haddow, 1., Faix, 1., Brown, R., Hermos, R., Pulkkinen, A, et al. (1991). Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf), 35(1), Kvetny, 1., Heldgaard, P., Bladbjerg, E., & Gram, 1. (2004). Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol (Oxf), 61(2), Ripoli, A, Pingitore, A, Favilli, B., Bottoni, A, Turchi, S., Osman, N., et al. (2005). Does subclinical hypothyroidism affect cardiac pump performance? Evidence from a magnetic resonance imaging study. JAm Col! Cardiol, 45(3), Smallridge, R., Glinoer, D., Hollowell, J., & Brent, G. (2005). Thyroid function inside and outside of pregnancy: what do we know and what don't we know? Thyroid, 15(1), Somwaru, L., Arnold, A., Joshi, N., Fried, L., & Cappola, A (2009). High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J Clin Endocrinol Metab, 94(4), Reid, S., Middleton, P., Cossich, M., & Crowther, C. (2010). Surks, M., Ortiz, E., Daniels, G., Sawin, c., Col, N., Cobin, R., et al. (2004). Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA, 291(2),
23 SH and its managements 17 Vaidya, B., Anthony, S., Bilous, M., Shields, B., Drury, J., Hutchison, S., et al. (2007). Detection of thyroid dysfunction in early pregnancy: Universal screening or targeted high-risk case finding? J Clin Endocrinol Metab, 92(1), Vanderpump, M., Tunbridge, W., French, 1., Appleton, D., Bates, D., Clark, F., et al. (1995). The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 43(1),55-68.
24 SH and its managements 18 Table 1 Differential Diagnosis of Subclinical Hypothyroidism: Other Causes that Increase TSH "..,,; Other.'conditions':eievatin' ~~TSH Po~slblecauses iiicre.~si~g TSH.{...:6>'.. f ~. f,.. ; :;;.':»::~:)~., i.' ".y ( fi i~y}0~?:i;2jli., '" Recovery form non-thyroidal illness Transient elevated TSH following TSH suppression Recovery from subacute, painless or postpartum thyroiditis Transient elevated TSH, but not always, following the hyperthyroid phase Subacute phase of hyperthyroidism Transient elevated TSH Laboratory analytical problem Untreated adrenal insufficiency Assay variability Treat adrenal insufficiency TSH - Secreting pituitary adenoma Central hypothyroidism Other possible causes for elevated TSH Previous radioiodine therapy, thyroid surgery or radiation and impaired renal function and rare mutations of the TSH receptor Source: "The clinical significance of subclinical thyroid dysfunction" (Biondi 2008).
25 SH and its managements 19 Flow Chart 1 Recommendations for Treatment of Subclinical Hypothyroidism TSH> 10 mull NO For those who do not have potential transient elevated TSH such as recovery from nonthyroidal illness, thyroiditis or radiation! surgery of thyroid, Start low dose of levothyroxine and regular monitoring of thyroid function with TSH serum concentration. YES TSH 5-10 mull For those who had risk factors such as 1. Cardiovascular risk factors such as hypertension, hyperlipidemia, diabetes mellitus, smoker 2. Positive TPO antibodies or evidence of autoimmune thyroditis 3. Pregnancy Consider initiating with low dose of levothyroxine with regular monitoring of thyroid function with TSH serum concentration NO TSH 5-10 mull..... For those who have negative risk factors cardiovascular disorder, TPO antibodies, and non- pregnancy and women over 60: 6-12 months intervals oftsh monitor Source: "The clinical significance of subclinical thyroid dysfunction" (Biondi 2008).
Subclinical Hypothyroidism
Subclinical Hypothyroidism Key Clinical Points Subclinical hypothyroidism is defined as an elevated thyrotropin level with a normal free thyroxine (T 4 ) level. To confirm the diagnosis, a transient increase
More informationHypothyroidism in pregnancy. Nor Shaffinaz Yusoff Azmi Jabatan Perubatan Hospital Sultanah Bahiyah Kedah
Hypothyroidism in pregnancy Nor Shaffinaz Yusoff Azmi Jabatan Perubatan Hospital Sultanah Bahiyah Kedah Agenda 1. Epidemiology and clinical characteristics of maternal hypothyroidism 2. Prevention and
More informationThyroid Function TSH Analyte Information
Thyroid Function TSH Analyte Information 1 2013-05-01 Thyroid-stimulating hormone (TSH) Introduction Thyroid-stimulating hormone (thyrotropin, TSH) is a glycoprotein with molecular weight of approximately
More informationSubclinical thyroid disorders. Mario Skugor M.D. FACE Associate Professor of Medicine CCLCM of CWRU Cleveland Clinic
Subclinical thyroid disorders Mario Skugor M.D. FACE Associate Professor of Medicine CCLCM of CWRU Cleveland Clinic Definitions: Individuals with elevation of TSH but normal thyroid hormone levels have
More informationLecture title. Name Family name Country
Lecture title Name Family name Country Nguyen Thy Khue, MD, PhD Department of Endocrinology HCMC University of Medicine and Pharmacy, MEDIC Clinic Hochiminh City, Viet Nam Provided no information regarding
More informationEvaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals
European Journal of Endocrinology (2007) 157 509 514 ISSN 0804-4643 CLINICAL STUDY Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals
More informationSome Issues in the Management of Hypothyroidism
Some Issues in the Management of Hypothyroidism Family Medicine Refresher Course April 6, 2016 Janet A. Schlechte, M.D. Disclosure of Financial Relationships Janet A. Schlechte, M.D. has no relationships
More informationSUBCLINICAL HYPOTHYROIDISM
SCIENTIFIC REVIEW AND CLINICAL APPLICATIONS CLINICIAN S CORNER Subclinical Thyroid Disease Clinical Applications Nananda F. Col, MD, MPP, MPH Martin I. Surks, MD Gilbert H. Daniels, MD SUBCLINICAL HYPOTHYROIDISM
More informationHypothyroidism in Women
Illustration istock Collection / thinkstockphotos.com T Hypothyroidism in Women Donna Dunn Thyroid disease is a major health issue in the United States. Approximately 20 million Americans have been diagnosed
More informationDisorders of Thyroid Function
Disorders of Thyroid Function Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Michael.mcdermott@ucdenver.edu Thyroid Hormone Axis Hypothalamus TRH
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,100 116,000 120M Open access books available International authors and editors Downloads Our
More informationPage 1. Understanding Common Thyroid Disorders. Cases. Topics Covered
Cases Understanding Common Thyroid Disorders Douglas C. Bauer, MD UCSF Division of General Internal Medicine No Disclosures 66 yr old female with 1 yr of fatigue and lassitude and no findings except TSH=8.2,
More informationShould every pregnant woman be screened for thyroid disease?
Should every pregnant woman be screened for thyroid disease? Tal Biron-Shental Rinat Gabbay-Benziv Is there a debate? Thyroid screening Guidelines Targeted case finding criteria Age > 30 years Personal
More informationNone. Thyroid Potpourri for the Primary Care Physician. Evaluating Thyroid Function. Disclosures. Learning Objectives
Thyroid Potpourri for the Primary Care Physician Ramya Vedula DO, MPH, ECNU Endocrinology, Diabetes and Metabolism Princeton Medical Group Assistant Professor of Clinical Medicine Rutgers Robert Wood Johnson
More informationEffect of Subclinical Thyroid Disease on Cardiac Function in Patients on Thyroid Replacement Therapy as Assessed by Radionuclide Ventriculography
Egyptian J. Nucl. Med., Vol. 8, No. 2, December 2013 55 Original Article, Cardiology Effect of Subclinical Thyroid Disease on Cardiac Function in Patients on Thyroid Replacement Therapy as Assessed by
More informationCommon Issues in Management of Hypothyroidism
Common Issues in Management of Hypothyroidism Family Medicine Refresher Course April 5, 2018 Janet A. Schlechte, M.D. Disclosure of Financial Relationships Janet A. Schlechte, M.D. has no relationships
More informationThyroid Disease in Cardiovascular Patients
Thyroid Disease in Cardiovascular Patients Stuart R. Chipkin, MD Research Professor, School of Public Health and Health Sciences University of Massachusetts Disclosure Stuart R. Chipkin, MD Nothing to
More informationSanjay B. Dixit, M.D. BHS Endocrinology Associates November 11, 2017
Sanjay B. Dixit, M.D. BHS Endocrinology Associates November 11, 2017 I will not be discussing this Outline of discussion Laboratory tests for thyroid function Diagnosis of hypothyroidism Treatment of
More informationThyrotoxicosis in Pregnancy: Diagnose and Management
Thyrotoxicosis in Pregnancy: Diagnose and Management Yuanita Asri Langi email: meralday@yahoo.co.id Endocrinology & Metabolic Division, Internal Medicine Department, Prof.dr.R.D. Kandou Hospital/ Sam Ratulangi
More informationSubclinical Hypothyroidism In Women: Will Screening And Early Detection Reduce Hyperlipidemia?
ISPUB.COM The Internet Journal of Advanced Nursing Practice Volume 5 Number 1 Subclinical Hypothyroidism In Women: Will Screening And Early Detection Reduce Hyperlipidemia? A Olson Citation A Olson. Subclinical
More informationLothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy
Lothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy Early diagnosis and good management of maternal thyroid dysfunction are essential to ensure minimal adverse effects on
More informationSUBCLINICAL OR MILD THYROID
SCIENTIFIC REVIEW AND CLINICAL APPLICATIONS CLINICIAN S CORNER Subclinical Thyroid Disease Scientific Review and Guidelines for Diagnosis and Management Martin I. Surks, MD Eduardo Ortiz, MD, MPH Gilbert
More informationBELIEVE MIDWIFERY SERVICES
TITLE: THYROID DISEASE IN PREGNANCY EFFECTIVE DATE: July, 2013 POLICY STATEMENT: Pregnancy changes significantly the values influenced by the serum thyroid binding hormone level (i.e., total thyroxine,
More informationUpdate In Hypothyroidism
Update In Hypothyroidism CME Away India & Sri Lanka March 23 - April 7, 2018 Richard A. Bebb MD, ABIM, FRCPC Consultant Endocrinologist Medical Subspecialty Institute Cleveland Clinic Abu Dhabi Copyright
More informationTable 1: Thyroid panel. Result (reference interval) TSH 89.5 miu/l ( ) Total T4 5.2 µg/dl ( ) T3 uptake 39% (22-35)
Introduction Thyroid disease is the second most common endocrine disorder (behind diabetes), and its prevalence increases with increasing age. The incidence of newly diagnosed thyroid cancer is increasing
More informationCARDIOVASCULAR DISEASE IS
ORIGINAL INVESTIGATION Association Between Increased Mortality and Mild Thyroid Dysfunction in Cardiac Patients Giorgio Iervasi, MD; Sabrina Molinaro, PhD; Patrizia Landi, BSc; Maria Chiara Taddei, BSc;
More informationLothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy.
Lothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy. Early diagnosis and good management of maternal thyroid dysfunction is essential to ensure minimal adverse effects on
More informationHow to manage hypothyroid disease in pregnancy
For mass reproduction, content licensing and permissions contact Dowden Health Media. FIRST OF 2 PARTS How to manage hypothyroid disease in pregnancy Pregnancy complicated by hypothyroidism puts mother
More informationStudy of correlation of TFTs and thyroid antibodies with lipid abnormalities and ECG changes in Hypothyroidism
Original article: Study of correlation of TFTs and thyroid antibodies with lipid abnormalities and ECG changes in Hypothyroidism Dr. Madhulika Mahashabde, Dr. Govind Shiddapur, Dr. Deepti Munjal, Dr. Kashyap
More informationThyroid and Antithyroid Drugs. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine April 2014
Thyroid and Antithyroid Drugs Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine April 2014 Anatomy and histology of the thyroid gland Located in neck adjacent to the 5 th cervical vertebra (C5). Composed
More informationDecoding Your Thyroid Tests and Results
Decoding Your Thyroid Tests and Results Wondering about your thyroid test results? Learn about each test and what low, optimal, and high results may mean so you can work with your doctor to choose appropriate
More informationManagement of Common Thyroid Disorders
Management of Common Thyroid Disorders Douglas C. Bauer, MD UCSF Division of General Internal Medicine No Disclosures Cases 68 yr old woman with new atrial fibrillation and no other findings except TSH=0.04,
More informationProject Title: Effectiveness of Screening and Treatment of
Project Title: Effectiveness of Screening and Treatment of Subclinical Hypo- or Hyperthyroidism Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 0 Gaither
More informationThyroid Screen (Serum)
Thyroid Screen (Serum) Patient: DOB: Sex: F MRN: Order Number: Completed: Received: Collected: Sample Type - Serum Result Reference Range Units Central Thyroid Regulation & Activity Total Thyroxine (T4)
More informationHypothyroidism. Definition:
Definition: Hypothyroidism Primary hypothyroidism is characterized biochemically by a high serum thyroidstimulating hormone (TSH) concentration and a low serum free thyroxine (T4) concentration. Subclinical
More informationSlide notes: This presentation provides information on Graves disease, a systemic autoimmune disease. Epidemiology, pathology, complications,
1 This presentation provides information on Graves disease, a systemic autoimmune disease. Epidemiology, pathology, complications, including ophthalmic complications, treatments (both permanent solutions
More informationLeft Ventricular Function In Subclinical Hypothyroidism
Clinical Proceedings. 2016;12(1):13-19 Original Article Left Ventricular Function In Subclinical Hypothyroidism NK Thulaseedharan, P Geetha, TM Padmaraj Department of Internal Medicine, Govt. Medical College
More informationMastering Thyroid Disorders. Douglas C. Bauer, MD UCSF Division of General Internal Medicine
Mastering Thyroid Disorders Douglas C. Bauer, MD UCSF Division of General Internal Medicine Cases 68 yr old female with new atrial fibrillation and no other findings except TSH=0.04, normal free T4 79
More informationThyroid disease and vascular risk
Clinical Medicine 2014 Vol 14, No 6: s1 s4 ENDOCRINOLOGY Thyroid disease and vascular risk Authors: Avais Jabbar, A Salman Razvi B ABSTRACT Subclinical hypothyroidism (SCH) is a common condition seen in
More information2004 Where Do We Go from Here? Summary of Working Group Discussions on Thyroid Function and Gestational Outcomes
THYROID Volume 15, Number 1, 2005 Mary Ann Liebert, Inc. 2004 Where Do We Go from Here? Summary of Working Group Discussions on Thyroid Function and Gestational Outcomes Joseph G. Hollowell, 1 Stephen
More informationHypothyroidism and Hyperthyroidism. Paul V. Tomasic, MD, MS, FACP, FACE Nevada AACE EFNE & Annual Meeting October 6, 2018
Hypothyroidism and Hyperthyroidism Paul V. Tomasic, MD, MS, FACP, FACE Nevada AACE EFNE & Annual Meeting October 6, 2018 Disclosures: None related to this program or presentation Objectives: Hypothyroidism
More informationThe Clinical Consequences and Diagnosis of Hypothyroidism
The Clinical Consequences and Diagnosis of Hypothyroidism VICKY A LEGRYS, KATHERINE HARTMANN, JOAN F WALSH ABBREVIATIONS: CVD = coronary vascular disease; FT 3 = free T 3 ; FT 4 = free T 4 ; T 3 = triiodothyronine;
More informationManagement of Common Thyroid Disorders
Cases Management of Common Thyroid Disorders Douglas C. Bauer, MD UCSF Division of General Internal Medicine No Disclosures 68 yr old female with new atrial fibrillation and no other findings except TSH=0.04,
More informationThe Presence of Thyroid Autoantibodies in Pregnancy
The Presence of Thyroid Autoantibodies in Pregnancy Dr. O Sullivan does not have any financial relationships with any commercial interests. KATIE O SULLIVAN, MD FELLOW, ADULT/PEDIATRIC ENDOCRINOLOGY ENDORAMA
More informationHolistic Medicine for the 21 st Century
Holistic Medicine for the 21 st Century David Brownstein, M.D. Center for Holistic Medicine 5821 W. Maple Rd. Ste. 192 West Bloomfield, MI 48322 248.851.1600 www.drbrownstein.com Overcoming Thyroid Disorders
More informationThyroid Disease. I have no disclosures. Overview TSH. Matthew Kim, M.D. July, 2012
Thyroid Disease I have no disclosures Matthew Kim, M.D. July, 2012 Overview Thyroid Function Tests Hyperthyroidism Hypothyroidism Subclinical Thyroid Disease Thyroid Nodules Questions TSH Best single screening
More informationThe Thyroid and Pregnancy OUTLINE OF DISCUSSION 3/19/10. Francis S. Greenspan March 19, Normal Physiology. 2.
The Thyroid and Pregnancy Francis S. Greenspan March 19, 2010 OUTLINE OF DISCUSSION 1. Normal Physiology 2. Hypothyroidism 3. Hyperthyroidism 4. Thyroid Nodules and Cancer NORMAL PHYSIOLOGY Iodine Requirements:
More informationSCREENING FOR THYROID DYSFUNCTION U S P S T F R E C O M M E N D A T I O N S T A T E M E N T M A R I A S T U R L A 8 M A Y 2015
SCREENING FOR THYROID DYSFUNCTION U S P S T F R E C O M M E N D A T I O N S T A T E M E N T M A R I A S T U R L A 8 M A Y 2015 BACKGROUND Thyroid dysfunction represents a continuum from asymptomatic biochemical
More informationClinical efficacy of therapeutic intervention for subclinical hypothyroidism during pregnancy
Clinical efficacy of therapeutic intervention for subclinical hypothyroidism during pregnancy R. Ju 1, L. Lin 2, Y. Long 2, J. Zhang 2 and J. Huang 2 1 Gynaecology and Obstetrics Department, Beijing Chuiyangliu
More informationAmerican Thyroid Association Guidelines for Detection of Thyroid Dysfunction
American Thyroid Association Guidelines for Detection of Thyroid Dysfunction Paul W. Ladenson, MD; Peter A. Singer, MD; Kenneth B. Ain, MD; Nandalal Bagchi, MD, PhD; S. Thomas Bigos, MD; Elliot G. Levy,
More informationTHE PHARMA INNOVATION - JOURNAL Assessment of Antithyroperoxidase Antibodies and Thyroid Hormones Among Sudanese Pregnant Women
Received: 01-09-2013 Accepted: 30-09-2013 ISSN: 2277-7695 CODEN Code: PIHNBQ ZDB-Number: 2663038-2 IC Journal No: 7725 Vol. 2 No. 9 2013 Online Available at www.thepharmajournal.com THE PHARMA INNOVATION
More informationEndocrine part two. Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy
Endocrine part two Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy Cushing's disease: increased secretion of adrenocorticotropic
More informationThyroid in the elderly. Akbar Soltani M.D. Endocrinology and Metabolism Research Center (EMRC) Shariati Hospital
Thyroid in the elderly Akbar Soltani M.D. Endocrinology and Metabolism Research Center (EMRC) Shariati Hospital soltania@tuma.ac.ir Case 1 A 79 year old female is seen because of a 6 month history of fatigue,
More informationThyroid Plus. Central Thyroid Regulation & Activity. Peripheral Thyroid Function. Thyroid Auto Immunity. Key Guide. Patient: DOB: Sex: F MRN:
Thyroid Plus Patient: DOB: Sex: F MRN: Order Number: Completed: Received: Collected: Sample Type - Serum Result Reference Range Units Central Thyroid Regulation & Activity Total Thyroxine (T4) 127 127
More informationApproach to thyroid dysfunction
Approach to thyroid dysfunction Alice Y.Y. Cheng, MD, FRCPC Twitter: @AliceYYCheng Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or
More informationB-Resistance to the action of hormones, Hormone resistance characterized by receptor mediated, postreceptor.
Disorders of the endocrine system 38 Disorders of endocrine system mainly are caused by: A-Deficiency or an excess of a single hormone or several hormones: - deficiency :can be congenital or acquired.
More informationHypothyroidism. National Endocrine and Metabolic Diseases Information Service
Hypothyroidism National Endocrine and Metabolic Diseases Information Service U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is hypothyroidism? Hypothyroidism occurs when
More informationRequesting and Management of abnormal TFTs.
Requesting and Management of abnormal TFTs. At the request of a number of GPs I have produced summary guidelines surrounding thyroid testing. These have been agreed with our Endocrinology leads Dr Bell
More informationUnderactive Thyroid. Diagnosis, Treatment & Controversies
Underactive Thyroid Diagnosis, Treatment & Controversies Dr. Asif Malik Humayun Consultant Endocrinologist Milton Keynes University Hospital NHS Foundation Trust Thyroid Hormone Control of metabolism
More informationInternational Journal of Research and Review E-ISSN: ; P-ISSN:
International Journal of Research and Review www.ijrrjournal.com E-ISSN: 2349-9788; P-ISSN: 2454-2237 Original Research Article Free Thyroid Hormones in Subclinical Hypothyroidism and Its Preponderance
More informationThyroid Disorders Towards a Healthy Endocrine System
Thyroid Disorders Towards a Healthy Endocrine System What are Thyroid Disorders? The thyroid is a butterfly-shaped gland in the middle of the lower neck. Through the release of hormones, the thyroid regulates
More informationThyroid Disorders. January 2019
Thyroid Disorders January 2019 What is the Thyroid? The thyroid is a small butterfly-shaped gland inside the neck, located in front of the trachea (windpipe) and below the larynx (voicebox). It produces
More informationMichaela Granfors, Helena Åkerud, Anna Berglund, Johan Skogö, Inger Sundström-Poromaa, and Anna-Karin Wikström
ORIGINAL ARTICLE Endocrine Care Thyroid Testing and Management of Hypothyroidism During Pregnancy: A Population-based Study Michaela Granfors, Helena Åkerud, Anna Berglund, Johan Skogö, Inger Sundström-Poromaa,
More informationuniversity sciences of Isfahan university Com
Introduce R. Gholamnezhad Lecturer of school of nursing & midwifery of Iran university Ph.D student tof Immunology, Sh School of medical sciences of Isfahan university E-Mail: Gholami278@gmail. Com Interpreting
More informationReference intervals are derived from the statistical distribution of values in the general healthy population.
Position Statement Subject: Thyroid Function Testing for Adult Diagnosis and Monitoring Approval Date: July 2017 Review Date: July 2019 Review By: Chemical AC, Board of Directors Number: 1/2017 Introduction:
More informationUpdate on Gestational Thyroid Disease. Aidan McElduff The Discipline of Medicine, The University of Sydney
IADPSG 2016 Update on Gestational Thyroid Disease Aidan McElduff The Discipline of Medicine, The University of Sydney IADPSG 2016 DISCLOSURES and AIM Nil to disclose Aim: to provide an overview 2017 Guidelines
More informationMonitoring Levothyroxine Dose during Pregnancy: A Prospective Study
American Journal of Infectious Diseases 7 (3): 75-79, 2011 ISSN 1553-6203 2011 Science Publications Monitoring Levothyroxine Dose during Pregnancy: A Prospective Study 1 Juhi Agarwal, 1 Sirimavo Nair and
More informationThyroid and Antithyroid Drugs. Dr. Alia Shatanawi Feb,
Thyroid and Antithyroid Drugs Dr. Alia Shatanawi Feb, 24 2014 Anatomy and histology of the thyroid gland Located in neck adjacent to the 5 th cervical vertebra (C5). Composed of epithelial cells which
More informationAssessment of the Cardiovascular Risk in Subclinical Hypothyroidism
Page128 Assessment of the Cardiovascular Risk in Subclinical Hypothyroidism Anand Pyati* 1, Sudharani Dhuttargi 2, Nagaraj 1, Debasmita Das 3 1 Department of Biochemistry, BLDEU s Shri B M Patil Medical
More informationUniversal Screening Versus Case Finding for Detection and Treatment of Thyroid Hormonal Dysfunction During Pregnancy
J Clin Endocrin Metab. First published ahead of print February 3, 2010 as doi:10.1210/jc.2009-2009 ORIGINAL ARTICLE Endocrine Care Universal Screening Versus Case Finding for Detection and Treatment of
More informationEsther Briganti. Fetal And Maternal Health Beyond the Womb: hot topics in endocrinology and pregnancy. Endocrinologist and Clinician Researcher
Fetal And Maternal Health Beyond the Womb: hot topics in endocrinology and pregnancy Esther Briganti Endocrinologist and Clinician Researcher Director, Melbourne Endocrine Associates Associate Professor,
More informationObjectives. Medical Complications of Pregnancy. Potential Conflicts: None. Common Complicating Medical Conditions that Precede Pregnancy
Medical Complications of Potential Conflicts: None Ellen W. Seely, M.D. Director of Clinical Research Endocrine-Hypertension Division Brigham and Women s Hospital Professor of Medicine Harvard Medical
More informationISSN X (Print) Original Research Article
Scholars Journal of Applied Medical Sciences (SJAMS) Sch. J. App. Med. Sci., 2017; 5(11F):4737-4741 Scholars Academic and Scientific Publisher (An International Publisher for Academic and Scientific Resources)
More informationA Study on Prevalence of Co-Morbidities among Hypothyroidism Patients in Various Hospitals- Palakkad.
Human Journals Research Article June 2017 Vol.:9, Issue:3 All rights are reserved by Sweety George et al. A Study on Prevalence of Co-Morbidities among Hypothyroidism Patients in Various Hospitals- Palakkad.
More informationconcentration in young people.
NAOSITE: Nagasaki University's Ac Title Author(s) Citation Prevalence of antithyroid antibodie concentration in young people. Sekitani, Yui; Hayashida, Naomi; Ka Kozlovsky, Alexander; Yamashita, Sh Clinical
More informationSubclinical Hypothyroidism Something or Nothing? E. Chester Ridgway University of Colorado SOM August 1-2, 2008
Subclinical Hypothyroidism Something or Nothing? E. Chester Ridgway University of Colorado SOM August 1-2, 2008 Case: A 78 y/o female who is cold with fatigue, dry skin, and poor memory. Free T4 = 1.2
More informationDiagnostic Significance of Subclinical Hypothyroidism in Health Check-ups
ORIGINAL ARTICLES Diagnostic Significance of Subclinical Hypothyroidism in Health Check-ups Saori Hashimoto 1 Katsuji Ikekubo 1 Kanako Ika 1 Yuriko Kurahashi 1 Kaoru Takahashi 1 Yoshindo Kida 1 Tsutomu
More information344 Thyroid Disorders
344 Thyroid Disorders Definition/Cut-Off Value Thyroid dysfunctions that occur in pregnant and postpartum women, during fetal development, and in childhood are caused by the abnormal secretion of thyroid
More informationThyroid function testing in pregnancy: 2017 ATA guidelines update. Dr Simon Forehan
Thyroid function testing in pregnancy: 2017 ATA guidelines update Dr Simon Forehan Several factors are known to tax gravid thyroid economy: Increased plasma volume TBG pool increased Renal clearance Feto-placental
More informationThe interpretation and management of thyroid disorders
Journal of Endocrinology, Metabolism and Diabetes of South Africa 2015 ; 20(2) http://dx.doi.org/10.1080/16089677.2015.1056468 Open Access article distributed under the terms of the Creative Commons License
More informationCROSS TOWN ENDOCRINE CLUB. Alex S. Stagnaro-Green, M.D. THURSDAY, OCTOBER 22, 2009
CROSS TOWN ENDOCRINE CLUB Alex S. Stagnaro-Green, M.D. Professor of Medicine, Professor of Obstetrics & Gynecology Touro University College of Medicine Hackensack, New Jersey USC School of Medicine Visiting
More informationSample Type - Serum Result Reference Range Units. Central Thyroid Regulation Surrey & Activity KT3 4Q. Peripheral Thyroid D Function mark
Thyroid Plus Sample Type - Serum Result Reference Range Units Central Thyroid Regulation Surrey & Activity KT3 4Q Total Thyroxine (T4)
More informationPregnancy & Thyroid. Zohreh Moosavi Associate professor of Endocriology Imam Reza General Hospital Mashad University. Imam Reza weeky Conferance
Pregnancy & Thyroid Zohreh Moosavi Associate professor of Endocriology Imam Reza General Hospital Mashad University Imam Reza weeky Conferance Objectives Thyroid Disorders & Pregnancy Normal thyroid phsyiology
More informationIncreased Pregnancy Loss Rate in Thyroid Antibody Negative Women with TSH Levels between 2.5 and 5.0 in the First Trimester of Pregnancy
JCEM ONLINE Brief Report Endocrine Care Increased Pregnancy Loss Rate in Thyroid Antibody Negative Women with TSH Levels between 2.5 and 5.0 in the First Trimester of Pregnancy Roberto Negro, Alan Schwartz,
More informationSubclinical Thyroid Dysfunction, Cardiac Function, and the Risk of Heart Failure
Journal of the American College of Cardiology Vol. 52, No. 14, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.07.009
More informationReview Article Think Thyroid - Think Life: Pregnancy with Thyroid Disorders
Chettinad Health City Medical Journal Muthukumaran Jayapaul* Consultant Endocrinologist, Arka Center for Hormonal Health, Chennai, India Dr. Muthu Kumaran Jayapaul is a Consultant Endocrinologist and also
More informationHeart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output
Cardiac Anatomy Heart Failure Professor Qing ZHANG Department of Cardiology, West China Hospital www.blaufuss.org Cardiac Cycle/Hemodynamics Functions of the Heart Essential functions of the heart to cover
More informationThyroid Function. Thyroid Antibodies. Analyte Information
Thyroid Function Thyroid Antibodies Analyte Information - 1-2013-04-30 Thyroid Antibodies Determination of thyroid autoantibodies are, besides TSH and FT4, one of the most important diagnostic parameters.
More informationSubclinical Hypothyroidism: When to Treat, When to Watch
DOUGLAS S. ROSS, MD Harvard University Subclinical Hypothyroidism: When to Treat, When to Watch Dr Ross is professor of medicine at Harvard Medical School in Boston and a physician at Massachusetts General
More informationHyperthyroidism. Objectives. Clinical Manifestations. Slide 1. Slide 2. Slide 3. Implications for Primary Care. hyperthyroidism
1 Hyperthyroidism Implications for Primary Care Laura A. Ruby, DNP, CRNP Wellspan Endocrinology 2 Objectives! Discuss the clinical manifestations of hyperthyroidism! Review the use of the diagnostic studies!
More informationTrust Guideline for the Management of: Abnormal Pre-operative Thyroid Function Tests in Adults. Anaesthetists Abnormal Pre-op Thyroid Function Test
For Use in: By: For: Pre-operative Thyroid Function Tests in Adults Division responsible for document: Key words: Name and job titles of document author: Name and job title of document author s Line Manager:
More informationThyroid Disease: The Subtle, the Controversial, and the Complex
Thyroid Disease: The Subtle, the Controversial, and the Complex Learning Objectives After participating in this educational activity, participants should be better able to 1. Recognize the common and less
More informationUniversal TSH screening to detect hypothyroidism in pregnancy : a comprehensive review
The University of Toledo The University of Toledo Digital Repository Master s and Doctoral Projects Universal TSH screening to detect hypothyroidism in pregnancy : a comprehensive review Andrea M. Fox
More informationLimits of Liability/Disclaimer of Warranty
Page 0 of 8 Limits of Liability/Disclaimer of Warranty The author, Brad Shook has made their best effort to produce a high quality and informative reference. The author makes no representation or warranties
More informationHYPERTHYROIDISM IS A COMmon
ORIGINAL CONTRIBUTION Thyroid Function and Mortality in Patients Treated for Hyperthyroidism Jayne A. Franklyn, MD, PhD Michael C. Sheppard, PhD, FRCP Patrick Maisonneuve, PhD See also Patient Page. Context
More informationDiscontinuation of Smoking Increases the Risk for Developing Thyroid Peroxidase Antibodies and/or Thyroglobulin Antibodies: A Prospective Study
ORIGINAL ARTICLE Endocrine Care Brief Report Discontinuation of Smoking Increases the Risk for Developing Thyroid Peroxidase Antibodies and/or Thyroglobulin Antibodies: A Prospective Study Grigoris Effraimidis,
More informationClinical THYROIDOLOGY
Clinical THYROIDOLOGY Editor-in Chief Jerome M. Hershman, MD Distinguished Professor of Medicine UCLA School of Medicine and VA Greater Los Angeles Healthcare System Endocrinology 111D, 11301 Wilshire
More informationScreening for Thyroid Disease
DRAFT FOR CONSULTATION Screening for Thyroid Disease A draft report for the UK National Screening Committee February 2013 This report has been compiled by Dr Gail Pittam, Senior Researcher Dr Martin Allaby,
More informationHigher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death
European Journal of Endocrinology (2009) 160 985 991 ISSN 0804-4643 CLINICAL STUDY Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death N
More information